The National Institute on Aging, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the U.S. Patents and Patent Applications listed in the Supplementary Information section of this notice to VeriLuce Therapeutics (``VLT'') located in Toronto, ON, Canada.
Document
Prospective Grant of Exclusive Patent License: Composition and Methods for Delivering Inhibitory Oligonucleotides for the Treatment of Pancreatic Cancer
The National Institute on Aging, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent Li...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
82 FR 31783
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Prospective Grant of Exclusive Patent License: Composition and Methods for Delivering Inhibitory Oligonucleotides for the Treatment of Pancreatic Cancer,” thefederalregister.org (July 10, 2017), https://thefederalregister.org/documents/2017-14370/prospective-grant-of-exclusive-patent-license-composition-and-methods-for-delivering-inhibitory-oligonucleotides-for-the.